Urologic Oncology   

Questions discussed in this category

Does this raise concerns about the efficacy of adjuvant immune checkpoint inhibition? Are any preliminary results from AMBASSADOR (adjuvant pembrolizu...

The forest plot from CheckMate 274 did not show a benefit for such patients? How would you select between adjuvant chemotherapy and adjuvant nivoluma...

Is a 3 month delay too long in someone who had postoperative complications?

Is there a benefit to cytoreductive nephrectomy if residual metastases are not resected? Any benefit to extending surgery to other metastatic sites?

GS 4+4. PSA low (1-2). CT and bone scan negative for lymphadenopathy or metastatic disease.  Prostate MRI pending. 

Wouldn't lymph node dissection improve sensitivity of staging and inform adjuvant treatment decisions?

Based on the RADICALS-RT trial presented at ESMO, can RT be omitted in post op prostate patients in favor of salvage RT? If not which group of patient...

Should cystectomy remain standard of care? (Recently debated in JAMA Oncology: http://jamanetwork.com/journals/jamaoncology/article-abstract/2520055...

Papers discussed in this category

BJU international, 2012-10

Clinical genitourinary cancer, 2018-12

J Urol, 2020 Apr

Lancet, 2020 Mar 05

Urology, 2000-11-01

Abdom Radiol (NY), 2019 Aug 29

Lancet Oncol, 2021 May 26

N Engl J Med,

Lancet Oncol, 2021 Mar 12

N. Engl. J. Med., 2012-04-19